Jacobs Levy Equity Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-81,579
| Closed | -$210K | – | 1069 |
|
|
2024
Q2 | $210K | Buy |
+81,579
| New | +$210K | ﹤0.01% | 918 |
|
|
2023
Q1 | – | Sell |
-123,821
| Closed | -$2.29M | – | 1076 |
|
|
2022
Q4 | $2.29M | Sell |
123,821
-794,454
| -87% | -$14.7M | 0.02% | 528 |
|
|
2022
Q3 | $24.8M | Buy |
918,275
+854,755
| +1,346% | +$23.1M | 0.2% | 137 |
|
|
2022
Q2 | $878K | Sell |
63,520
-2,931
| -4% | -$40.5K | 0.01% | 776 |
|
|
2022
Q1 | $1.3M | Sell |
66,451
-169,073
| -72% | -$3.3M | 0.01% | 713 |
|
|
2021
Q4 | $3.84M | Buy |
+235,524
| New | +$3.84M | 0.03% | 486 |
|
|
2020
Q1 | – | Sell |
-65,176
| Closed | -$1.06M | – | 1111 |
|
|
2019
Q4 | $1.06M | Sell |
65,176
-182,115
| -74% | -$2.96M | 0.01% | 681 |
|
|
2019
Q3 | $3.22M | Buy |
247,291
+8,444
| +4% | +$110K | 0.04% | 412 |
|
|
2019
Q2 | $3.1M | Buy |
+238,847
| New | +$3.1M | 0.04% | 437 |
|
|
2016
Q3 | – | Sell |
-51,400
| Closed | -$699K | – | 1151 |
|
|
2016
Q2 | $699K | Sell |
51,400
-31,490
| -38% | -$428K | 0.01% | 676 |
|
|
2016
Q1 | $1.45M | Buy |
+82,890
| New | +$1.45M | 0.03% | 487 |
|